Core Viewpoint - Rongjie Health (300247.SZ) expects a significant increase in net profit for the fiscal year 2025, projecting a net profit attributable to shareholders of between 75 million to 88 million yuan, representing a year-on-year growth of 60.07% to 87.82% [1] Financial Performance - The company forecasts a net profit excluding non-recurring gains and losses of 70 million to 83 million yuan, indicating a year-on-year increase of 77.78% to 110.79% [1] - Overall sales revenue has shown continuous growth during the reporting period, supported by various initiatives [1] Operational Improvements - The company has implemented measures such as expanding production capacity, optimizing the supply chain, enhancing operational efficiency, and innovating processes, which have contributed to the increase in sales [1] - The overall gross profit margin has also improved compared to the same period last year [1]
融捷健康:预计2025年度归母净利润7500万元至8800万元,同比增长60.07%至87.82%